Translational Health Sciences is part of the Bristol Medical School. Staff and students are based in high-quality research and clinical settings across the city, including the Bristol Royal Infirmary, Southmead Hospital and the advanced laboratory facilities in the Dorothy Hodgkin Building. The school undertakes laboratory-based, translational and applied research, fostering a high level of collaboration between staff and students. It comprises a mix of basic and medically trained scientists, enabling high-quality collaborative translational and healthcare research using a wide range of techniques - from molecular biology to epidemiology. Our work focuses on clinical research and a significant part of this has translated to clinical trials that are led by the school. These include ongoing trials related to: cardiac surgery uveitis childhood vaccination and anti-microbial therapy treatment of obesity in childhood and adult life therapies for diabetic neuropathy treatment of early Alzheimer's disease neurosurgical approaches to Parkinson's disease immunotherapy and bone marrow stem cell therapy in multiple sclerosis interventions for treatment of neonatal brain injury type 1 diabetes prevention improvement of outcomes from joint replacement novel methods of glucocorticoid treatment in critical illness and inflammatory disorders treatment of nephrotic syndrome management of pleural disease. These studies are complemented by translational clinical studies, engaging both clinical and basic scientists. School staff are leaders in their fields, with extensive national and international research collaborations providing a wide range of skills that contribute to a first-class working environment in which to undertake interdisciplinary research and teaching. The majority of our postgraduate students develop into highly productive researchers publishing in leading peer-reviewed journals. Most go on to postdoctoral research in academia and industry, both in the UK and overseas.